We just received data on a new analyst forecast for $NBIX. H.C. Wainwright gave a rating of 'Buy' for $NBIX.
$NBIX Analyst Ratings
Wall Street analysts have issued reports on $NBIX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- H.C. Wainwright issued a "Buy" rating on 04/22/2025
- Morgan Stanley issued a "Overweight" rating on 02/04/2025
- UBS issued a "Buy" rating on 01/08/2025
- Raymond James issued a "Underperform" rating on 10/29/2024
To track analyst ratings and price targets for $NBIX, check out Quiver Quantitative's $NBIX forecast page.
$NBIX Price Targets
Multiple analysts have issued price targets for $NBIX recently. We have seen 3 analysts offer price targets for $NBIX in the last 6 months, with a median target of $150.0.
Here are some recent targets:
- An analyst from Morgan Stanley set a target price of $150.0 on 03/07/2025
- Ashwani Verma from UBS set a target price of $162.0 on 01/08/2025
- Evan David Seigerman from BMO Capital set a target price of $121.0 on 10/31/2024
$NBIX Insider Trading Activity
$NBIX insiders have traded $NBIX stock on the open market 48 times in the past 6 months. Of those trades, 0 have been purchases and 48 have been sales.
Here’s a breakdown of recent trading of $NBIX stock by insiders over the last 6 months:
- KEVIN CHARLES GORMAN has made 0 purchases and 5 sales selling 156,930 shares for an estimated $23,201,551.
- KYLE GANO (Chief Executive Officer) has made 0 purchases and 6 sales selling 70,079 shares for an estimated $9,848,055.
- STEPHEN A SHERWIN sold 13,831 shares for an estimated $1,613,922
- JUDE ONYIA (Chief Scientific Officer) has made 0 purchases and 4 sales selling 5,336 shares for an estimated $649,885.
- MATT ABERNETHY (Chief Financial Officer) has made 0 purchases and 4 sales selling 4,821 shares for an estimated $610,967.
- EIRY ROBERTS (Chief Medical Officer) has made 0 purchases and 5 sales selling 4,655 shares for an estimated $596,752.
- DARIN LIPPOLDT (Chief Legal Officer) has made 0 purchases and 4 sales selling 4,345 shares for an estimated $553,852.
- ERIC BENEVICH (Chief Commercial Officer) has made 0 purchases and 4 sales selling 4,341 shares for an estimated $551,966.
- JULIE COOKE (Chief Human Resources Officer) has made 0 purchases and 5 sales selling 3,991 shares for an estimated $529,946.
- INGRID DELAET (Chief Regulatory Officer) has made 0 purchases and 6 sales selling 3,879 shares for an estimated $514,116.
- DAVID W. BOYER (Chief Corp. Affairs Officer) has made 0 purchases and 4 sales selling 3,589 shares for an estimated $460,056.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NBIX Hedge Fund Activity
We have seen 275 institutional investors add shares of $NBIX stock to their portfolio, and 296 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DODGE & COX added 1,728,605 shares (+134.2%) to their portfolio in Q4 2024, for an estimated $235,954,582
- CITADEL ADVISORS LLC added 773,519 shares (+43.8%) to their portfolio in Q4 2024, for an estimated $105,585,343
- WELLINGTON MANAGEMENT GROUP LLP added 739,199 shares (+102.9%) to their portfolio in Q4 2024, for an estimated $100,900,663
- THRIVENT FINANCIAL FOR LUTHERANS added 711,970 shares (+2759.4%) to their portfolio in Q4 2024, for an estimated $97,183,905
- ARMISTICE CAPITAL, LLC added 710,619 shares (+391.8%) to their portfolio in Q4 2024, for an estimated $96,999,493
- ORBIMED ADVISORS LLC added 635,900 shares (+210.4%) to their portfolio in Q4 2024, for an estimated $86,800,350
- QUBE RESEARCH & TECHNOLOGIES LTD removed 618,244 shares (-81.0%) from their portfolio in Q4 2024, for an estimated $84,390,306
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
